Free Trial
NASDAQ:SYRA

Syra Health (SYRA) Stock Price, News & Analysis

Syra Health logo
$0.36 -0.02 (-5.33%)
(As of 11/15/2024 ET)

About Syra Health Stock (NASDAQ:SYRA)

Key Stats

Today's Range
$0.35
$0.38
50-Day Range
$0.36
$1.00
52-Week Range
$0.34
$8.37
Volume
219,115 shs
Average Volume
769,699 shs
Market Capitalization
$3.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.

Syra Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
21st Percentile Overall Score

SYRA MarketRank™: 

Syra Health scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Syra Health.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Syra Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Syra Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Syra Health has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Syra Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.24% of the float of Syra Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Syra Health has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Syra Health has recently decreased by 19.98%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Syra Health does not currently pay a dividend.

  • Dividend Growth

    Syra Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.24% of the float of Syra Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Syra Health has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Syra Health has recently decreased by 19.98%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Syra Health has a news sentiment score of -0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Syra Health this week, compared to 7 articles on an average week.
  • Search Interest

    Only 1 people have searched for SYRA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Syra Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Syra Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,015.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    10.18% of the stock of Syra Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.75% of the stock of Syra Health is held by institutions.

  • Read more about Syra Health's insider trading history.
Receive SYRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syra Health and its competitors with MarketBeat's FREE daily newsletter.

SYRA Stock News Headlines

Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
Syra Madad
Zacks Small Cap Increases Earnings Estimates for Syra Health
See More Headlines

SYRA Stock Analysis - Frequently Asked Questions

Syra Health's stock was trading at $1.0157 at the start of the year. Since then, SYRA stock has decreased by 65.0% and is now trading at $0.3551.
View the best growth stocks for 2024 here
.

Syra Health Corp. (NASDAQ:SYRA) released its quarterly earnings results on Tuesday, October, 29th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.15. The firm had revenue of $2.25 million for the quarter, compared to analyst estimates of $1.99 million. Syra Health had a negative net margin of 54.90% and a negative trailing twelve-month return on equity of 131.94%.

Syra Health (SYRA) raised $7 million in an initial public offering on Friday, September 29th 2023. The company issued 1,600,000 shares at a price of $4.13 per share. Kingswood served as the underwriter for the IPO.

Shares of SYRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Syra Health investors own include American Airlines Group (AAL), Meta Platforms (META), PACCAR (PCAR), Super Micro Computer (SMCI), Arista Networks (ANET), Darden Restaurants (DRI) and Fabrinet (FN).

Company Calendar

Last Earnings
10/29/2024
Today
11/15/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/24/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Employment agencies
Sub-Industry
Business Services
Current Symbol
NASDAQ:SYRA
Previous Symbol
NASDAQ:SYRA
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Net Income
$-2,940,000.00
Pretax Margin
-54.90%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Book Value
$0.34 per share

Miscellaneous

Free Float
8,809,000
Market Cap
$3.48 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NASDAQ:SYRA) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners